Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?
Publication
, Journal Article
Ramacciotti, E; Agati, LB; Caffaro, RA; Volpiani, GG; Lopes, RD; Comerota, AJ; Fareed, J
Published in: Clin Appl Thromb Hemost
2019
Direct oral anticoagulants (DOACs) are now widely used for the management of venous thromboembolism (VTE) that now includes cancer-associated thrombosis. This review summarizes recent data on VTE prophylaxis and treatment, new challenges, guidelines, and updates as well as the current place for DOACs on the emerging cancer-associated VTE management landscape.
Duke Scholars
Published In
Clin Appl Thromb Hemost
DOI
EISSN
1938-2723
Publication Date
2019
Volume
25
Start / End Page
1076029619856433
Location
United States
Related Subject Headings
- Venous Thromboembolism
- Thrombosis
- Neoplasms
- Humans
- Disease Management
- Cardiovascular System & Hematology
- Anticoagulants
- Administration, Oral
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ramacciotti, E., Agati, L. B., Caffaro, R. A., Volpiani, G. G., Lopes, R. D., Comerota, A. J., & Fareed, J. (2019). Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019? Clin Appl Thromb Hemost, 25, 1076029619856433. https://doi.org/10.1177/1076029619856433
Ramacciotti, Eduardo, Leandro B. Agati, Roberto Augusto Caffaro, Giuliano G. Volpiani, Renato D. Lopes, Anthony J. Comerota, and Jawed Fareed. “Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?” Clin Appl Thromb Hemost 25 (2019): 1076029619856433. https://doi.org/10.1177/1076029619856433.
Ramacciotti E, Agati LB, Caffaro RA, Volpiani GG, Lopes RD, Comerota AJ, et al. Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019? Clin Appl Thromb Hemost. 2019;25:1076029619856433.
Ramacciotti, Eduardo, et al. “Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?” Clin Appl Thromb Hemost, vol. 25, 2019, p. 1076029619856433. Pubmed, doi:10.1177/1076029619856433.
Ramacciotti E, Agati LB, Caffaro RA, Volpiani GG, Lopes RD, Comerota AJ, Fareed J. Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019? Clin Appl Thromb Hemost. 2019;25:1076029619856433.
Published In
Clin Appl Thromb Hemost
DOI
EISSN
1938-2723
Publication Date
2019
Volume
25
Start / End Page
1076029619856433
Location
United States
Related Subject Headings
- Venous Thromboembolism
- Thrombosis
- Neoplasms
- Humans
- Disease Management
- Cardiovascular System & Hematology
- Anticoagulants
- Administration, Oral
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology